Koninklijke Philips Receives FDA Clearance

Koninklijke Philips N.V said pre-market Thursday it received regulatory clearance from the U.S. Food and Drug Administration to market its IntelliSite Pathology Solution.

The FDA evaluated data from a clinical study of approximately 2,000 surgical pathology cases. “The clearance for Philips IntelliSite Pathology Solution marks a major milestone for innovation in pathology services in the U.S.,” said Russ Granzow, General Manager of Philips Digital Pathology Solutions. “Not only will it promote increased efficiencies and collaboration between pathologists, but it also opens a complete new dimension towards computational pathology.”

By Bucky Rini